Schizophrenia

A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

CONTACT

845-988-HEMP

contact@fusioncbd.com

Want to learn more and try Fusion CBD for free?

Let’s grow together #fusionfam

© 2017 - 2020 Fusion Holding Group. All Rights Reserved.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.